Skip to main content
Top
Published in: Indian Journal of Surgery 5/2023

21-01-2023 | Computed Tomography | Original Article

New Diagnostic Marker for Crohn’s Disease — Ileocecal Lipomatosis

Authors: Hasan Börekci, Hatice Baş

Published in: Indian Journal of Surgery | Issue 5/2023

Login to get access

Abstract

Inflammatory bowel disease is one of the most common clinical conditions in industrialized countries. Crohn’s disease is a chronic inflammatory condition that can cause lesions from the mouth to the anus. It is a progressive disease and may cause many intestinal and extraintestinal complications. Therefore, early diagnosis and disease management are very important. The aim of this research is to explore new parameters that help facilitate the diagnosis of Crohn’s disease. Medical history, physical examination, and histological and microbial examinations are accepted for diagnosis, but studies on anatomical changes are quite inadequate. There are reports that increased ileocecal lipomatosis diameter may be associated with inflammation. But, the relationship between the diameter of ileocecal lipomatosis and Chron’s disease has never been discussed before. Patients diagnosed with Crohn’s disease (n=102) and patients not diagnosed with Crohn’s disease (n=77) were included in this study. The mean diameter of ileocecal lipomatosis between the two groups was compared by evaluating CT images. The values were significantly higher in the Crohn’s disease positive group than in the Crohn’s disease negative group (p=0.001). The increase in diameter in ileocecal lipomatosis may be a useful marker for the diagnosis of Crohn’s disease. Further research is recommended to understand the relationship between Crohn’s disease and ileocecal lipomatosis.
Literature
1.
go back to reference Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, Sung JJY, Kaplan GG (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390(10114):2769–2778CrossRefPubMed Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, Sung JJY, Kaplan GG (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390(10114):2769–2778CrossRefPubMed
2.
go back to reference Roda G, Ng SC, Kotze PG, Argollo M, Panaccione R, Spinelli A, Kaser A, Peyrin-Biroulet L, Danese S (2020) Crohn’s disease Nat Rev Dis Primers 6:1–19CrossRef Roda G, Ng SC, Kotze PG, Argollo M, Panaccione R, Spinelli A, Kaser A, Peyrin-Biroulet L, Danese S (2020) Crohn’s disease Nat Rev Dis Primers 6:1–19CrossRef
3.
go back to reference Torres J, Mehandru S, Colombel JF, Peyrin- Biroulet L (2017) Crohn’s disease. Lancet 389:1741–1755CrossRefPubMed Torres J, Mehandru S, Colombel JF, Peyrin- Biroulet L (2017) Crohn’s disease. Lancet 389:1741–1755CrossRefPubMed
4.
go back to reference Peyrin-Biroulet L, Loftus EV, Colombel JF, Sandborn WJ (2010) The natural history of adult Crohn’s disease in population-based cohorts. Am J Gastroenterol 105:289–297CrossRefPubMed Peyrin-Biroulet L, Loftus EV, Colombel JF, Sandborn WJ (2010) The natural history of adult Crohn’s disease in population-based cohorts. Am J Gastroenterol 105:289–297CrossRefPubMed
5.
go back to reference Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV (2010) Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology 139:1147–1155CrossRefPubMed Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV (2010) Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology 139:1147–1155CrossRefPubMed
6.
go back to reference Fiorino G, Bonifacio C, Peyrin- Biroulet L, Danese S (2016) Preventing collateral damage in Crohn’s disease: the Lémann index. J Crohns Colitis 10:495–500CrossRefPubMedPubMedCentral Fiorino G, Bonifacio C, Peyrin- Biroulet L, Danese S (2016) Preventing collateral damage in Crohn’s disease: the Lémann index. J Crohns Colitis 10:495–500CrossRefPubMedPubMedCentral
8.
go back to reference Shanahan F (2001) Inflammatory bowel disease: immunodiagnostics, immunotherapeutics and ecotherapeutics. Gastroenterology 120:622–635CrossRefPubMed Shanahan F (2001) Inflammatory bowel disease: immunodiagnostics, immunotherapeutics and ecotherapeutics. Gastroenterology 120:622–635CrossRefPubMed
11.
go back to reference Panes J, Bouzas R, Chaparro M et al (2011) Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther 34:125–145CrossRefPubMed Panes J, Bouzas R, Chaparro M et al (2011) Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther 34:125–145CrossRefPubMed
12.
go back to reference Ordas I, Rimola J, Rodriguez S et al (2014) Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn’s disease. Gastroenterology 146:374–382CrossRefPubMed Ordas I, Rimola J, Rodriguez S et al (2014) Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn’s disease. Gastroenterology 146:374–382CrossRefPubMed
13.
go back to reference Tawfik OW, McGregor DH (1992) Lipohyperplasia of the ileocecal valve. Am J Gastroenterol 87(1):82–87PubMed Tawfik OW, McGregor DH (1992) Lipohyperplasia of the ileocecal valve. Am J Gastroenterol 87(1):82–87PubMed
14.
go back to reference Börekci H, Serin Hİ, Baş H, Börekci E (2020) Relationship between appendicitis and diameter of ileocecal lipomatosis and also ileocecal angle. Surg Radiol Anat 42:437–441CrossRefPubMed Börekci H, Serin Hİ, Baş H, Börekci E (2020) Relationship between appendicitis and diameter of ileocecal lipomatosis and also ileocecal angle. Surg Radiol Anat 42:437–441CrossRefPubMed
15.
go back to reference Parlak S, Okay AE, Altin L, Toprak U, Kuscuoglu G, Karademir MA (2014) Lipomatosis of terminal ileum and ileocecal valve: multidetector computed tomography findings. Iran J Radiol 11(3):e4336CrossRefPubMedPubMedCentral Parlak S, Okay AE, Altin L, Toprak U, Kuscuoglu G, Karademir MA (2014) Lipomatosis of terminal ileum and ileocecal valve: multidetector computed tomography findings. Iran J Radiol 11(3):e4336CrossRefPubMedPubMedCentral
16.
go back to reference Wilkins T, Jarvis K, Patel J (2011) Diagnosis and management of Crohn’s disease. Am Fam Physician 84:1365–1375PubMed Wilkins T, Jarvis K, Patel J (2011) Diagnosis and management of Crohn’s disease. Am Fam Physician 84:1365–1375PubMed
17.
go back to reference Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE (2018) ACG clinical guideline: management of Crohn’s disease in adults [published correction appears in adults]. Am J Gastroenterol 113:481–517CrossRefPubMed Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE (2018) ACG clinical guideline: management of Crohn’s disease in adults [published correction appears in adults]. Am J Gastroenterol 113:481–517CrossRefPubMed
18.
go back to reference Kappelman MD, Moore KR, Allen JK, Cook SF (2013) Recent trends in the prevalence of Crohn’s disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci 58:519–525CrossRefPubMed Kappelman MD, Moore KR, Allen JK, Cook SF (2013) Recent trends in the prevalence of Crohn’s disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci 58:519–525CrossRefPubMed
19.
go back to reference Wang YR, Loftus EV Jr, Cangemi JR, Picco MF (2013) Racial/ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States. Digestion 88:20–25CrossRefPubMed Wang YR, Loftus EV Jr, Cangemi JR, Picco MF (2013) Racial/ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States. Digestion 88:20–25CrossRefPubMed
20.
go back to reference Ananthakrishnan AN (2015) Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 12:205–217CrossRefPubMed Ananthakrishnan AN (2015) Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 12:205–217CrossRefPubMed
21.
go back to reference Waugh N, Cummins E, Royle P, Kandala NB, Shyangdan D, Arasaradnam R, Clar C, Johnston R (2013) Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Health Technol Assess 17:1–211CrossRefPubMedPubMedCentral Waugh N, Cummins E, Royle P, Kandala NB, Shyangdan D, Arasaradnam R, Clar C, Johnston R (2013) Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Health Technol Assess 17:1–211CrossRefPubMedPubMedCentral
22.
go back to reference Berk RN, Davis GB, Cholhassey EB (1973) Lipomatosis of the ileocecal valve. Am J Roentgenol Radium Therapy, Nucl Med 119:323–328CrossRef Berk RN, Davis GB, Cholhassey EB (1973) Lipomatosis of the ileocecal valve. Am J Roentgenol Radium Therapy, Nucl Med 119:323–328CrossRef
23.
go back to reference World Health Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. WHO Technical Report Series 894, World Health Organization, Geneva World Health Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. WHO Technical Report Series 894, World Health Organization, Geneva
24.
go back to reference Veauthier B, Hornecker JR (2018) Crohn’s disease: diagnosis and management. Am Fam Physician 98:661–669PubMed Veauthier B, Hornecker JR (2018) Crohn’s disease: diagnosis and management. Am Fam Physician 98:661–669PubMed
25.
go back to reference Bounthavong M, Li M, Watanabe JH (2017) An evaluation of health care expenditures in Crohn’s disease using the United States Medical Expenditure Panel Survey from 2003 to 2013. Res Soc Adm Pharm 13:530–538CrossRef Bounthavong M, Li M, Watanabe JH (2017) An evaluation of health care expenditures in Crohn’s disease using the United States Medical Expenditure Panel Survey from 2003 to 2013. Res Soc Adm Pharm 13:530–538CrossRef
Metadata
Title
New Diagnostic Marker for Crohn’s Disease — Ileocecal Lipomatosis
Authors
Hasan Börekci
Hatice Baş
Publication date
21-01-2023
Publisher
Springer India
Published in
Indian Journal of Surgery / Issue 5/2023
Print ISSN: 0972-2068
Electronic ISSN: 0973-9793
DOI
https://doi.org/10.1007/s12262-023-03693-4

Other articles of this Issue 5/2023

Indian Journal of Surgery 5/2023 Go to the issue

Images in Surgery

Hidrocystoma on Forehead

Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare